Fadi Haddad
UT MD Anderson · M.D. Anderson Cancer Center · Sharp HealthCare
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fadi Haddad as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:36 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07604233 · Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AMLM.D. Anderson Cancer Center · not yet recruiting · Myeloid Leukemia · principal investigator
- Ph2NCT07269470 · Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic PhaseM.D. Anderson Cancer Center · recruiting · Chronic Myeloid Leukemia · principal investigator
- Ph2NCT06817720 · Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or AsciminibM.D. Anderson Cancer Center · recruiting · Chronic Myeloid Leukemia · principal investigator
- N/ANCT04402814 · IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.Fadi Haddad, M.D. · unknown · SARS-CoV 2 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:36 UTC. The ranking covers the 200 most relevant of 112 PubMed records, and a shared surname and initials can bring in a namesake. All 112 on PubMed
- Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial.Lancet Haematol · 2023236 citationsRCR 20.8
- A prospective analysis of fenestrated endovascular grafting: intermediate-term outcomes.Eur J Vasc Endovasc Surg · 2006211 citationsRCR 7.8
- Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.Circ Res · 2013209 citationsRCR 6.2
- 189 citationsRCR 15.4
- Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.Antimicrob Agents Chemother · 2019180 citationsRCR 9.9
- Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.Circulation · 2013139 citationsRCR 3.9
- Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise.J Appl Physiol (1985) · 2005135 citationsRCR 3.8
- Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension.Eur Respir J · 2017131 citationsRCR 5.0
- 126 citationsRCR 11.0
- 104 citationsRCR 11.6